ArticleAACE endocrinology and diabetes
Life-Threatening Neck Hematoma After Fine-Needle Aspiration of a Thyroid Nodule in a Patient With End-Stage Renal Disease.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Ultrasound-guided fine needle aspiration (FNA) of thyroid nodules is a widely performed and generally safe procedure with a low complication rate. While minor bleeding and small hematomas are relatively common, the occurrence of a large, life-threatening hematoma is exceedingly rare. This case report describes a patient who developed a delayed, severe cervical hematoma several days after undergoing thyroid FNA. We review contributing risk factors and propose strategies to help minimize such complications. Case Report: A 68-year-old female patient with past medical history of end stage renal disease (ESRD) underwent FNA for a suspicious left thyroid nodule. Patient was not taking anticoagulants or antiplatelet medication and had no known coagulopathy other than ESRD. While initially the procedure was well tolerated without complications, 3 days later the patient presented with large neck swelling and airway compromise. She was subsequently intubated and underwent drainage of 5.2 × 3.1 × 12.3 cm retropharyngeal hematoma. The patient recovered with mild persistent hoarseness of voice. Discussion: Though rare, delayed hematoma after thyroid FNA can be life-threatening. Risk may be higher in patients with ESRD, highly vascular nodules, or when certain biopsy devices are used. Coagulation labs may not fully reflect bleeding risk in dialysis patients. Clinicians should educate patients about warning signs such as neck swelling or breathing changes and consider closer follow-up in high-risk cases. Conclusion: Thyroid FNA is generally safe, but rare delayed bleeding complications can occur. Early recognition and airway management are essential for good outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.